Edward Younker The number of specialty drugs on the market has increased massively over recent decades, with brand name drug use rising from around 5% in 1975 to about 45% by 2008. There is a growing feeling that this increase may be skewing prescribing practices and fueling high costs for healthcare payers (policies like Medicare Part D). … Read more
A class action lawsuit has been filed against the makers of Invokana, a diabetes drug that was linked to 22 reports of diabetic ketoacidosis. Suing Merck and its subsidiary Ortho-McNeil-Janssen Pharmaceuticals Inc., the complaint seeks compensation for people who have suffered as a result of taking Invokana. According to a research published in the journal … Read more
America is in the midst of a public health crisis that has been fueled by rising rates of opioid addiction. The solution to this problem lies with increased access to safe and effective medications, but it will require cooperation from pharmaceutical corporations. There are many ways for legislators and citizens alike to challenge their reliance … Read more
Products that aren’t regulated have a lot to offer, but when companies ignore the law and sell products without FDA approval or other official oversight, this can have disastrous effects on consumers. One such example of 不完全管理事項有可能實際上造成人和財產的損失。 The “what agency protects consumers” is a question that has been asked many times. There are 5 products … Read more